Document is current
Any future updates will be listed below
-
Authors
Singh, Purnima
Crossman, David K.
Cheng, Changde
Trainor, Patrick J.
Sharafeldin, Noha
Wang, Xuexia
Zhou, Liting
Hageman, Lindsey
Armenian, Saro H.
Balis, Frank M.
Hawkins, Douglas S.
Keller, Frank G.
Hudson, Melissa M.
Neglia, Joseph P.
Ginsberg, Jill P.
Landier, Wendy
Bhatia, Smita
-
Funding
Funding for this research was provided by:
National Cancer Institute (R35CA220502)
Leukemia and Lymphoma Society (6563-19)
The V Foundation (DT2019-010)
National Clinical Trials Network Operations Center Grant (U10CA180886)
National Clinical Trials Network Statistics & Data Center Grant (U10CA180899)
National Cancer Institute Community Oncology Research Program Grant (UG1CA189955)
Community Clinical Oncology Program Grant (U10CA095861)
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 6 May 2025
First Online: 17 May 2025
Declarations
:
: COG member institutions contributed participants to the study after obtaining approval from local institutional review boards. Written informed consent/assent was obtained from patients and/or parents/legal guardians. City of Hope (IRB-03066) and The University of Alabama at Birmingham Institutional Review Board (IRB-150115006) approved all experimental protocols and methods. All methods were performed in accordance with the ethical standards of City of Hope and University of Alabama at Birmingham Institutional Review Board and with the 1964 Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.
